Simplex Trading
SWTX

Simplex Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Simplex Trading’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,000
Closed -$18K – 10039
2025
Q2 		$18K Sell
34,000
-76,800
-69% -$3.42M ﹤0.01% 6875
2025
Q1 		$4.89M Buy
110,800
+100,500
+976% +$4.63M ﹤0.01% 1321
2024
Q4 		$372K Sell
10,300
-8,900
-46% -$311K ﹤0.01% 3846
2024
Q3 		$615K Hold
19,200
– – ﹤0.01% 3369
2024
Q2 		$723K Buy
19,200
+18,700
+3,740% +$787K ﹤0.01% 3257
2024
Q1 		$24K Sell
500
-20,000
-98% -$925K ﹤0.01% 6963
2023
Q4 		$748K Buy
20,500
+19,800
+2,829% +$517K ﹤0.01% 3307
2023
Q3 		$16K Sell
700
-400
-36% -$10.9K ﹤0.01% 6838
2023
Q2 		$28K Buy
+1,100
New +$28.9K ﹤0.01% 6431
2023
Q1 		– Sell
-1,600
Closed -$41K – 10103
2022
Q4 		$41K Sell
1,600
-4,900
-75% -$121K ﹤0.01% 6119
2022
Q3 		$185K Sell
6,500
-9,300
-59% -$267K ﹤0.01% 4725
2022
Q2 		$388K Sell
15,800
-10,700
-40% -$391K ﹤0.01% 3768
2022
Q1 		$1.5M Buy
26,500
+25,600
+2,844% +$1.46M ﹤0.01% 2409
2021
Q4 		$55K Buy
900
+800
+800% +$52.9K ﹤0.01% 7142
2021
Q3 		$8K Hold
100
– – ﹤0.01% 9072
2021
Q2 		$8K Buy
+100
New +$7.59K ﹤0.01% 9246

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's SWTX Position: Q2 2025 in Review

Simplex Trading sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 46,435 shares — an estimated $2.07M sold.

Simplex Trading first reported a position in SWTX in Q2 2022 and held it in 8 quarters. The position peaked at $2.05M in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Simplex Trading reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 46,435 SpringWorks Therapeutics shares in Q2 2025, an estimated $2.07M.
  • Simplex Trading first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 8 quarters.
  • Simplex Trading's SpringWorks Therapeutics position peaked at $2.05M in Q1 2025.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.